According to Mirati Therapeutics's latest financial reports the company's current revenue (TTM) is C$51.8 M. In 2022 the company made a revenue of C$16.87 M a decrease over the revenue in the year 2021 that were of C$91.23 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.